Emily Fox

And the posting is now live! Let me know if you have any questions about the ID Pharmacist/Clinical Coordinator ASP position. bit.ly/4gMu2Cl #IDX #IDTwitter @TwitteRX

@GranulicaTESSA 👏🏼👏🏼👏🏼👏🏼so awesome 💙💛

We learned, we laughed, we built relationships, & most importantly we bettered patient care. To say I am humbled to be a part of the WVU Medicine Antimicrobial SOS (ASOS) team and to help lead this group across the state of WV is an understatement. #EveryoneIsAnABXSteward

A moment to reflect: When I started at @WVUMedicine after residency in 2019, I was 1 of 4 Infectious Diseases pharmacists at Ruby Memorial Hospital. Fast forward 5 years and I am now 1 of 10 ID pharmacists within our WVU Medicine health system (4 in the system, 6 at Ruby)

@nancyclovir @AmpC_Stabler @MDAndersonNews @dont_joshme @jjjaiimee @LinK_PharmD @KelseyOlson33 These titles never disappoint 👏🏼

Well done Citywide presentation by @AmpC_Stabler 👏👏 🎉🎉 @MDAndersonNews @dont_joshme @jjjaiimee @LinK_PharmD @KelseyOlson33

@raneempallotta Empirically our hospitals have been at 3.375 Q8 EI. Now increasing to 4.5 Q8 EI for confirmed MIC of 16. Considering increasing to 4.5 for empiric pseudomonas dosing but < 10% of our PsA isolates locally have MICs of 16 of greater

How are you approaching pip/tazo MIC 16 SDD? (New breakpoint) #IDTwitter

🆕️🔥 Single centre cohort study @StanfordASP @bluPharmD @DHpharmd &🌟s* In immunocompromised pts with Invasive Mucormycosis neither upfront nor salvage antifungal combo Rx was associated with a difference in 6 week mortality compared to monotherapy academic.oup.com/ofid/advance-a…

Calling all PGY1s interested in infectious diseases🚨🦠We are recruiting for our next ID PGY2 resident at @ProvOregonIDASP in Portland, OR🌲⛰️ Schedule a 30-min virtual session at the link below or meet with us at PPS for more info 👇🏼 gme.providence.org/pharmacy-resid…

How many people are going to stop and ask about this today? 😂🤔 @nancyclovir @FoxEPharmD @OncIDPharmd @SarahSpitznogle @FTverdek @jjjaiimee

@mmPharmD @PharmerMeg @EricMacyMD @KimberlyBlumen1 Just came up for me today! Thankful for this thread 🙏🏻 we didn’t end up bridging

#IDTwitter #TwitteRx Pt w anaphylaxis to BLs. Needs IM PCN x3. You desens. Do you need to bridge with PO PCN in between 💉? Will IM levels remain high enough to not require 2nd desens/allergic Rx? @PharmerMeg @EricMacyMD @KimberlyBlumen1

@PharmaSpence @ryankshields has papers describing pip-tazo regaining susceptibility following resistance development to C/T. Not sure about FDC though! ncbi.nlm.nih.gov/pmc/articles/P… We’ve seen this occur a few times at MDA, imi-rel may be worth testing?

@RalphTayyarMD @DHpharmd @Stanford_Med_ID Woohoo!! Go David! 💯

So proud of our one and only Dr. David Ha discussing antimicrobial stewardship in intraabdominal infections @DHpharmd @Stanford_Med_ID #SHEASpring2023

Pursuing ID PGY2 in phase 2 of the @ASHPOfficial match?!? Check us out! 🦠 We still have a spot available @CRMHRxResidency & will be in Phase 2 of the Match! Check out our program: #program-description" target="_blank" rel="nofollow noopener">carilionclinic.org/pharmacy-resid… DM if there are any questions! #IDTwitter #RxTwitter

The @OURxResidency PGY-2 ID pharmacy residency will be going into phase 2 of the match. Want to train at an AMC with a variety of experiences including OPAT and transplantID? Please share. pharmacy.ouhsc.edu/programs/resid…

Want to do an ASHP-accredited ID residency at an academic medical center and didn’t match (or participate) in Phase I? @UMMCPharmacy has a PGY2 ID spot that will be participating in Phase II. We’d love to have your application! Contact me with questions. umc.edu/SOP/Department…

📣 The @BaptistHealthSF @BHAcademics ID PGY2 pharmacy residency will be going to phase 2 of the match. 🙏 Please pass the word along to potential candidates looking for a robust training experience academics.baptisthealth.net/residencies-an… #MatchDay #PharmacyResidency #TwitteRx #IDtwitter

Seeking contributors for a new #WikiGuideline project – Care of Patients Who Inject Drugs (#PWID). Come be part of our team and help improve the care of these marginalized patients. Sign up here by 4/1/23: forms.office.com/r/Tyb8R0iM8X @NNolanMD @rachelpbaden #SUD #PWUD #Addiction

@TarynEubank @Evan_Steere @SageGreenlee @MeganHardwick1 @tydrake5 👏🏼👏🏼👏🏼👏🏼 you love to see it

A project started during my PGY2 was carried across the finish line!! Super proud of @Evan_Steere hard work and excellent end product. Also HIGHLY recommend publishing with your besties ☺️☺️ @SageGreenlee @MeganHardwick1 @tydrake5

A 🆕️⚡️Small retrospective single study in immunocompromised patients Poor clinical outcomes of Piperacillin/tazobactam Vs cefepime or carbapenems for AmpC-producing organisms MERINO 2 no definitive answer! Meta/Dr. Lee? No difference An RCT ? #IDTwitter academic.oup.com/jac/advance-ar…